Skip to main content
01274 442076
Heart failure pharmacist: How PCNs Can Strengthen Follow-up
|
Getting your Trinity Audio player ready...
|
- What can a heart failure pharmacist do in primary care?
- How can a heart failure pharmacist organise heart failure follow up?
- When should a PCN involve the heart failure multidisciplinary team?
- What does the evidence show about Clinical Pharmacy support?
- Illustrative example – not a treatment protocol
- What should a PCN commission for heart-failure follow-up?
A heart failure pharmacist can help a PCN create a consistent route for review, monitoring and escalation. This gives leaders ownership and a visible worklist. Decisions remain within competence, governance and local pathways.
Key Takeaways
- NICE says primary care should lead a full heart-failure review and recall people at least every six months.
- Heart failure monitoring needs action after a clinical or treatment change.
- A heart failure pharmacist model needs clinical time, preparation, supervision, escalation and cover.
What can a heart failure pharmacist do in primary care?
A heart failure pharmacist coordinates records, medicines reconciliation, patient contact and escalation in a PCN. In heart failure primary care, this makes work visible and accountable.
An independent-prescribing Clinical Pharmacist may assess, decide and prescribe within competence, scope and governance. A non-prescribing Clinical Pharmacist can review and escalate decisions. A Pharmacy Technician prepares records, reconciles information and arranges recalls under supervision. The GPhC confirms that independent prescribers may prescribe autonomously within their clinical competence.
Record HFrEF or HFpEF, the current plan and unresolved questions. Clinical pharmacist support can add governed capacity.
How can a heart failure pharmacist organise heart failure follow up?
A heart failure pharmacist can organise heart failure follow up with a worklist and specialist route.
- Identify and prepare. Search for due reviews, discharge changes, missing results and actions.
- Review and optimise. Use a heart failure medication review to reconcile changes and confirm the plan. Link complex work to medicines optimisation.
- Monitor and recall. Heart failure monitoring shows results, contacts and safety actions.
- Communicate and escalate. Record the next heart failure follow up. Escalate concerns outside local scope.
A heart failure primary care pathway needs a named clinical lead and review cadence. It does not replace a local heart failure clinic. Use structured medication reviews for complexity or medicines concerns.
Heart failure QOF can support planned recall and register quality. It should sit alongside local safety, follow-up and escalation measures.
Need a governed heart-failure follow-up pathway across your PCN?
Discuss heart failure pharmacy supportWhen should a PCN involve the heart failure multidisciplinary team?
Under NICE, the heart failure multidisciplinary team manages new, recently decompensated and advanced cases. It optimises treatment and starts medicines that need specialist supervision. Primary care leads ongoing review and arranges specialist access when needed.
Seek specialist input for clinical uncertainty or work outside scope. NICE recommends monitoring within days to two weeks after a change in condition or treatment. Stable heart failure still needs at least six-monthly recall.
What does the evidence show about Clinical Pharmacy support?
A 2025 UK service evaluation at a two-site GP practice included 237 people with heart failure. It reported optimal guideline-directed therapy rising from 17.7% to 94.5% over two years. It used trained Clinical Pharmacists, protocols and GP or nurse support. Read the service evaluation.
This is encouraging local evidence, not a promise of identical results. It was retrospective, non-randomised and had no comparator group. Several outcome and cost estimates were modelled.
Illustrative example – not a treatment protocol
A Pharmacy Technician reconciles a discharge change and prepares the worklist. A Clinical Pharmacist completes a heart failure medication review and records the next action. An independent prescriber acts within scope, or the concern goes to a GP or specialist.
What should a PCN commission for heart-failure follow-up?
Commission the complete pathway, not only appointments.
| Resource | What to specify |
|---|---|
| Clinical time | Protected Clinical Pharmacy sessions and a defined prescribing route. |
| Preparation | Pharmacy Technician and administration time for searches, reconciliation, recalls and results. |
| Governance | Supervision, escalation criteria, specialist access and audit. |
| Resilience | Absence cover, handover and a dashboard for due reviews and actions. |
| Performance measures | Track Heart failure QOF alongside due reviews, unresolved actions, safety exceptions and escalation. |
Expert insight from Adeem Azhar, qualified Clinical Pharmacist and CEO
A sustainable heart-failure pathway makes the right work visible with high impact. It protects time for clinical judgement and creates a clear route to escalate concerns. It makes follow-up safer and more consistent.
Adeem Azhar, MPharm, IPres
Co-Founder and Chief Executive Officer – Core Prescribing Solutions
Qualified Clinical Pharmacist
FAQs
Build reliable heart-failure follow-up with the right pharmacy capacity
Core Prescribing Solutions can support GP practices and PCNs with Clinical Pharmacist and Pharmacy Technician capacity for defined heart-failure workstreams. We can help organise review worklists, medicines reconciliation, monitoring, recall and escalation within agreed clinical scope, local pathways and governance arrangements.
Discuss your heart failure follow-up requirements
